Jun 11, 2019|3 min readBy Ilene SchneiderTaking it straight to the eyeVector platform delivers gene therapy to the retina
Jan 28, 2018|2 min readBy DDNews StaffAbeona Receives RMATFirst gene therapy RMAT designation for epidermolysis bullosa enables accelerated approval path and real world data usage
Oct 05, 2017|3 min readBy Mel J. YeatesAbeona announces ABO-102 trial dataAbeona Therapeutics has announced one year data from Cohort 1 of the ongoing ABO-102 Phase 1/2 trial for Sanfilippo syndrome Type A (MPS IIIA).
Nov 09, 2016|3 min readBy Lori LeskoA new option for Sanfilippo?Abeona’s preclinical data support gene therapy for rare disorder MPS IIIA
Sep 14, 2016|3 min readBy Ilene SchneiderSkin disease solutionAbeona engages in partnership for EB gene therapy treatments
Jun 09, 2015|3 min readBy Zack AnchorsMerger boosts development of Sanfilippo treatmentFollowing acquisition of Abeona, PlasmaTech plans to push company’s pipeline forward with two Phase 1/2 clinical trials in 2015